Find in Library

The present study was carried out to evaluate and compare in vitro antioxidant (2,2-diphenyl-1-picrylhydrazyl (DPPH), Trolox equivalent antioxidant capacity (TEAC), and ferric reducing antioxidant power (FRAP)), antimicrobial, anticancer activities, and the individual carotenoids and anthocyanins content of methanol extracts of the Cyclamen genotypes: Persian cyclamen accessions (<i>Cyclamen persicum</i> Mill.), sowbread (<i>C. mirabile</i> Hildebr.), and ivy-leaved cyclamen (<i>C. hederifolium</i> Mill.) aerial parts. The HPLC-PDA analysis revealed the presence of five individual carotenoids (i.e., neoxanthin, violaxanthin, lutein, β-carotene, and cis-β-carotene) as the main compounds in <i>Cyclamen</i> leaves, and the presence of seven individual anthocycanins (i.e., cyanidin 3,5-di-<i>O</i>-glucoside, peonidin-rutinoside, peonidin 3,5-di-<i>O</i>-glucoside, peonidin 3-<i>O</i>-glucoside, malvidin 3-<i>O</i>-glucoside, malvidin 3,5-di-<i>O</i>-glucoside, and malvidin-rutinoside) in Cyclamen flowers reported, hereby, for the first time. The highest phenolic content was found in the leaves of LC6, <i>C. mirabile</i> (46.32 ± 0.14 mg/g gallic acid equivalents [GAE]), and in the flowers of <i>C. persicum</i> Merengue Magenta (FC15) (58.63 ± 0.17 mg/g GAE), whereas the highest flavonoid content was reported in <i>C. persicum</i> Halios Falbala leaves, namely LC9 (54.90 ± 0.27 mg/g quercetin equivalents [QE]) and in flowers of <i>C. persicum</i> Victora (FC2) (77.87 ± 0.25 mg/g QE). The highest antioxidant activity in DPPH and FRAP assays was reported in <i>C. persicum</i> Dark Violet (LC1) and Victoria (LC2), whereas <i>C. mirabile</i> (LC6) had the highest activity in the TEAC assay. In flowers, high antioxidant activities in DPPH and TEAC were noticed in <i>C. persicum</i> Superserie Red (FC7) and Dark Violet (FC1), respectively, and Halios Falbala (FC9) exhibited the highest activity in the TEAC assay. Additionally, FC9 exhibited the highest antibacterial activity in almost all tested bacteria compared with the leaves extracts. Furthermore, the highest in vitro citotoxicity in MDA-MB-231 cells was noticed in <i>C. hederifolium</i> LC18 (56.71–69.35%) and FC18 (40.07–41.43%), with a lower effect against BJ cells demonstrating selective toxicity. The above findings, highlight the potential use of the Cyclamen flower and leaf extracts as significant anticancer agents along with their antioxidant and antimicrobial properties.